Pharsight Monthly Summary
December, 2022
Recent happenings in patent protected drugs.
spacer_11
At a Glance
24
drug patents lapsed
Photos
56
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
SANTEN
 
VERTEX PHARMS INC
 
GENZYME CORP
 
TAIHO ONCOLOGY
 
ALNYLAM PHARMS INC
 
 
spacer_11
Drugs not protected by patents anymore
Drug Company
COMBIGAN ALLERGAN
LUSEDRA EISAI INC
MACRILEN NOVO
CHANTIX PF PRISM CV
VELCADE TAKEDA PHARMS USA
ABILIFY OTSUKA
LEXAPRO ALLERGAN
ABILIFY MYCITE KIT OTSUKA
VIMPAT UCB INC
FOLOTYN ACROTECH
TEFLARO ALLERGAN
BEYAZ BAYER HLTHCARE
VIIBRYD ALLERGAN
FUSILEV ACROTECH
SAXENDA NOVO
BANZEL EISAI INC
TOVIAZ PFIZER
CAPRELSA GENZYME CORP
ADDYI SPROUT PHARMS
AMLODIPINE BESYLATE SYNTHON PHARMS
Drug patents lapsed
Drug Patent Patent expiry
AMLODIPINE BESYLATE US6828339 Nov, 2022
BANZEL US6740669 Nov, 2022
HETLIOZ US5856529 Dec, 2022
HETLIOZ LQ US5856529 Dec, 2022
OCALIVA US7138390 Nov, 2022
PROMACTA US7160870 Nov, 2022
PROMACTA KIT US7160870 Nov, 2022
See more
Newly introduced Drug Patents
Drug Patent Patent expiry
CERDELGA US11458119 Nov, 2030
LYTGOBI US9108973 Feb, 2033
LYTGOBI US10434103 Mar, 2036
OMLONTI US8648097 Oct, 2029
OMLONTI US10774072 Jun, 2035
OXLUMO US11446380 Oct, 2035
TRIKAFTA (COPACKAGED) US11453655 Dec, 2037
See more
Visit Pharsight
Someone forwarded you these interesting insights? Get these delivered in your inbox every month.
© 2022 GreyB Research